EUVIMEDEUVIMED entdecken
Crossref

Intrabody targeting of insulin receptor pY1150: A novel approach to modulate signaling pathways in colorectal cancer cells

Ha Gyeong Shin, Na-Oh Yunn, Ji Woong Kim, Yea Bin Cho, Sung Ho Ryu, Hyunbo Shim, Sukmook Lee

Cellular Signalling · 2025

DOI: 10.1016/j.cellsig.2025.112143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Ha Gyeong Shin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea. Hauptthemen laut MEDLINE: Receptor, Insulin, Colorectal Neoplasms, Signal Transduction, Single-Chain Antibodies. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Ministry of Education, National Research Foundation of Korea, Korea University of Technology and Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The activation of the insulin receptor (IR) is central to the regulation of physiological metabolism, growth, and proliferation, and is associated with various cancers, including colorectal cancer (CRC). Among the tyrosine residues in the intracellular kinase domain of IR, Tyr1150 plays a pivotal role in receptor activation by regulating substrate binding to the kinase active site. In this study, we introduce a novel approach for selectively modulating insulin signaling in CRC through the development of an intrabody targeting phosphorylated Tyr1150 (IR pY1150). Using phage display technology, we isolated a phosphorylation site-specific single-chain variable fragment (scFv), K109.1, from a human scFv antibody library, which specifically binds to IR pY1150. K109.1 was subsequently engineered as an intrabody designed to function within cells. Ectopic expression of K109.1 in CRC cells selectively inhibited insulin-mediated phosphorylation of key downstream effectors, including insulin receptor substrates and Akt, thereby leading to a significant reduction in insulin-dependent glucose uptake. Notably, K109.1 did not affect extracellular signal-regulated kinase phosphorylation or alter cell proliferation, migration, or invasion. We further evaluated K109.1 in BT-474 and HEK293 cells to assess its effects in additional cellular models. In BT-474 breast cancer cells, K109.1 selectively inhibited Akt phosphorylation, while in HEK293 cells it suppressed both Akt and ERK phosphorylation, indicating context-specific signaling responses. Taken together, these findings indicate that intrabody-mediated targeting of IR pY1150 is crucial for regulating glucose metabolism, suggesting that the developed antibody, K109.1, could serve as a tool for modulating insulin-mediated signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, InsulinColorectal NeoplasmsSignal TransductionSingle-Chain AntibodiesHumansPhosphorylationCell Line, TumorInsulinHEK293 CellsCell Proliferation

Stichwörter der Autor:innen

Colorectal cancerGlucose metabolismInsulin receptorIntrabodyTyrosine phosphorylation

Substanzen

Receptor, InsulinSingle-Chain AntibodiesInsulin

Autor:innen und Institutionen

  • Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
  • School of Energy, Materials and Chemical Engineering, Korea University of Technology and Education, Cheonan 31253, Republic of Korea.
  • Department of Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
  • Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
  • Department of Life Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea; Department of Chemistry, Kookmin University, Seoul 02707, Republic of Korea; Antibody Research Institute, Kookmin University…

Förderung

  • Ministry of Education
  • National Research Foundation of Korea
  • Korea University of Technology and Education
  • Korea Health Industry Development Institute

Zitieren

APA

Shin, H. G., Yunn, N. O., Kim, J. W., Cho, Y. B., Ryu, S. H., Shim, H., & Lee, S. (2025). Intrabody targeting of insulin receptor pY1150: A novel approach to modulate signaling pathways in colorectal cancer cells. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112143

Vancouver

Shin HG, Yunn NO, Kim JW, Cho YB, Ryu SH, Shim H, et al. Intrabody targeting of insulin receptor pY1150: A novel approach to modulate signaling pathways in colorectal cancer cells. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112143

BibTeX
@article{Shin2025,
  author = {Shin, Ha Gyeong and Yunn, Na-Oh and Kim, Ji Woong and Cho, Yea Bin and Ryu, Sung Ho and Shim, Hyunbo and Lee, Sukmook},
  title = {Intrabody targeting of insulin receptor pY1150: A novel approach to modulate signaling pathways in colorectal cancer cells},
  journal = {Cellular Signalling},
  year = {2025},
  doi = {10.1016/j.cellsig.2025.112143}
}
Kostenlos starten →